The TGF-ß Family in Glioblastoma.
Int J Mol Sci
; 25(2)2024 Jan 15.
Article
em En
| MEDLINE
| ID: mdl-38256140
ABSTRACT
Members of the transforming growth factor ß (TGF-ß) family have been implicated in the biology of several cancers. In this review, we focus on the role of TGFß and bone morphogenetic protein (BMP) signaling in glioblastoma. Glioblastoma (GBM) is the most common malignant brain tumor in adults; it presents at a median age of 64 years, but can occur at any age, including childhood. Unfortunately, there is no cure, and even patients undergoing current treatments (surgical resection, radiotherapy, and chemotherapy) have a median survival of 15 months. There is a great need to identify new therapeutic targets to improve the treatment of GBM patients. TGF-ßs signaling promotes tumorigenesis in glioblastoma, while BMPs suppress tumorigenic potential by inducing tumor cell differentiation. In this review, we discuss the actions of TGF-ßs and BMPs on cancer cells as well as in the tumor microenvironment, and their use in potential therapeutic intervention.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Encefálicas
/
Glioblastoma
/
Proteínas da Superfamília de TGF-beta
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Int J Mol Sci
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Suécia
País de publicação:
Suíça